Persistence Capital Appoints Segal

Persistence Capital Partners, a Canadian healthcare services investment firm, appointed Lloyd M. Segal as a Partner of the Fund. Segal was previously CEO of Thallion Pharmaceuticals, where he currently serves as Chairman.

25 February 2010•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles